ACT for Stroke Rehabilitation in India: Neuroregeneration After Stroke | ALIV

Medically Reviewed by Dr. Sunita Tandulwadkar | Written by ALIV

Stroke — the sudden interruption of blood supply to a region of the brain — produces neurological deficits whose severity depends on the location and extent of the affected brain tissue. Standard acute stroke management (thrombolysis, thrombectomy) aims to restore blood flow as rapidly as possible to minimise the extent of irreversible neuronal damage. Post-acute rehabilitation through physiotherapy, speech therapy, and occupational therapy drives neuroplasticity — the brain's capacity to reorganise function around the damaged region. ACT's role in stroke recovery targets this neuroplastic rehabilitation phase: it does not restore the dead tissue of the infarct, but supports the perilesional brain tissue that is capable of reorganisation and the broader neurological environment in which rehabilitation gains occur.

The Neuroregenerative Mechanism in Stroke Recovery

The peri-infarct zone — the brain tissue surrounding the core of the stroke that is damaged but not irreversibly lost — is the primary territory where neuroplasticity and functional recovery occur after stroke. This zone contains neurons that are functionally impaired by the inflammatory, oedematous, and ischaemic environment of the acute and subacute post-stroke period, but which retain capacity for recovery if this hostile environment is modified. ACT's neurotrophic factors (BDNF, NGF, VEGF) support neuronal survival and axonal regeneration in this zone; anti-inflammatory MSC signals reduce the chronic neuroinflammation that impairs neuroplasticity; and VEGF promotes angiogenesis — restoration of the microvascular blood supply to the peri-infarct zone that supports its metabolic needs during recovery. ACT for stroke at ALIV is offered in the post-acute phase — typically three months or more after the stroke event, once acute medical management is complete and the patient is in the rehabilitation phase. Very early post-stroke ACT (within days to weeks) is not an established clinical application and is not part of ALIV's programme. The three-month-plus timeline reflects the fact that the acute inflammatory cascade of stroke takes weeks to months to stabilise, and intervention in the acute phase would introduce growth factors into a still-evolving, complex inflammatory environment. See the results timeline: ACT results timeline.

Clinical Expectations and Patient Selection

The ideal ACT-stroke candidate has: completed the acute phase (minimum three months post-stroke); ongoing neurological deficits with meaningful residual function to support (patients with severe, global neurological deficit leaving minimal residual capacity benefit less); active engagement in rehabilitation (physiotherapy, speech therapy); and medical stability. Clinical goals include: accelerated physiotherapy gains (rehabilitation produces better functional outcomes when the neurological environment is more favourable); improved motor recovery of partially affected limbs; improved speech and language function (where Broca's or Wernicke's area is in the peri-infarct zone); and improved cognition and attention. Response is variable and individual.

How soon after a stroke can ACT be started?

ALIV's protocol for post-stroke ACT begins a minimum of three months after the stroke event — and for many patients, six months or more is appropriate. The rationale is not bureaucratic but biological: the brain's acute inflammatory response, oedema, and evolving infarct demarcation take months to stabilise, and early-phase growth factor delivery into this environment carries uncertain risks of exacerbating the inflammatory response. The rehabilitation phase (typically six to twenty-four months post-stroke) is when neuroplasticity is most active and when ACT's neurotrophic support is most clinically synergistic with rehabilitation efforts.

Can ACT be combined with physiotherapy after stroke?

Yes — and this combination is strongly recommended by ALIV. ACT provides the neurobiological environment; physiotherapy provides the experience-dependent neural activity that drives neuroplasticity. The two are synergistic: ACT without concurrent rehabilitation does not produce functional recovery (there is no neural activity to drive the reorganisation the neurotrophic factors support); rehabilitation without the neurotrophic support of ACT produces slower neuroplastic gains in the depleted post-stroke neural environment. Ideally, intensive physiotherapy and speech therapy are scheduled in the weeks to months following ACT administration to capitalise on the neurotrophic window.

Medically Reviewed by Dr. Sunita Tandulwadkar. This article is for informational purposes only and does not constitute medical advice. Therapies offered by ALIV are proprietary, experimental protocols and results vary by individual.